Rheumatology

Renal Cell Carcinoma

Questions discussed in this category

How would you treat a patient with active lupus nephritis (class 3/4) who requires PD-1 immunotherapy for refractory metastatic renal cell carcinoma?

2 Answers available

Would you consider single agent TKI for patient with metastatic renal cell carcinoma who developed biopsy proven giant cell arteritis days after starting immunotherapy?

Would active vasculitis present a contraindication to therapy?

1 Answer available

Papers discussed in this category

Lancet Oncol, 2019 Jan

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.

Related Topics in Rheumatology